High expression of these genes in 316 ER+/HER2- breast cancer patients who had undergone neoadjuvant chemotherapy was not associated with a decreased relapse-free survival in the KM Plotter cohort (Figures 2G, H). The gene discussed is ESR1; the disease is breast carcinoma.